Navigation Links
Inflammation worsens danger due to atherosclerosis
Date:1/21/2009

Stockholm, Sweden Current research suggests that inflammation increases the risk of plaque rupture in atherosclerosis. The related report by Ovchinnikova et al, "T cell activation leads to reduced collagen maturation in atherosclerotic plaques of ApoE-deficient- mice," appears in the February 2009 issue of The American Journal of Pathology.

Atherosclerosis is a disease of arterial blood vessels where fats, cholesterol, blood cells, and fibers form hardened plaques on the artery wall. These plaques restrict blood flow to tissues such as the heart and brain by narrowing the artery. Atherosclerosis can be caused by high blood pressure, high fat and high cholesterol diets, smoking, and diabetes. People with atherosclerotic plaques often show no symptoms for decades.

Atherosclerotic plaques consist of lipid cores covered by collagen fiber caps. These plaques can suddenly rupture, resulting in blood clots that completely block blood flow and lead to heart attack or stroke in otherwise healthy individuals. One potential cause of plaque rupture is the thinning of the collagen fiber cap covering the plaque.

Inflammatory cells are often observed at the site of plaque rupture. Researchers led by Dr. Gran K Hansson at the Karolinska Institute explored the role of inflammatory cells in atherosclerotic plaque rupture using an animal model of atherosclerosis with hyper-activated immune cells. They found that inflammation leads to a reduction of mature collagen in atherosclerotic plaques, leading to thinner caps that are more likely to rupture. They then identified a collagen-maturing enzyme, lysyl-oxidase (LOX), which represents a novel target in inflammation-induced plaque rupture.

The data from Ovchinnikova et al suggest "a novel mechanism by which adaptive immunity can modulate plaque stability - impairment of collagen maturation by T cell-dependent inflammation." These studies help unraveling the cause of myocardial in
'/>"/>

Contact: Angela Colmone
acolmone@asip.org
301-634-7953
American Journal of Pathology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Apolipoprotein(a): A natural regulator of inflammation
2. Vitamin E shows possible promise in easing chronic inflammation
3. Vitamin C lowers levels of inflammation biomarker considered predictor of heart disease
4. LIAI launches new division to look at novel approaches to heart disease and inflammation
5. Failure to bridle inflammation spurs atherosclerosis
6. Inflammation triggers cell fusions that could protect neurons, Stanford research shows
7. Bleeding, not inflammation, is major cause of early lung infection death
8. New study finds uncontrollable stress worsens symptoms of endometriosis
9. NYU scientists discover dangerous new method for bacterial toxin transfer
10. Moving in for the winter toxic brown recluse spiders pose danger
11. Endangered sawfish focus of national collection and recovery efforts

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...utes fish food is a matter of debate. A high-profi...lmost 50 percent of their carbon from trees and le...errestrial and aquatic ecosystems. , But new res... is not likely to be true. Algae provide a much ri...ng to research published this week in the Proceed...
(Date:11/24/2009)... is available in Spanish . , The presence o...of inflammatory substances in the blood, hinders t...y a research project of the University of Navarra ... at the School of Pharmacy. , The project, entit...tion to the control of body weight and inflammatio...
(Date:11/23/2009)....C. The community-associated strain of the deadly...ant to most common antibioticsposes a far greater ...its way into hospitals, according to a study in th.... , The new threat is easily picked up in fitne...as increased the overall burden of MRSA within hos...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 1Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 2Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 3Beijing Cancer Hospital Becomes First Hospital in Mainland China to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 51880 1Beijing Cancer Hospital Becomes First Hospital in Mainland China to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 51880 2Beijing Cancer Hospital Becomes First Hospital in Mainland China to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 51880 3Supelco 28R 29 and MIP Technologies Launch New SPE Product for the Selective Extraction of NSAIDs From Environmental Water 13058 1Supelco 28R 29 and MIP Technologies Launch New SPE Product for the Selective Extraction of NSAIDs From Environmental Water 13058 2Supelco 28R 29 and MIP Technologies Launch New SPE Product for the Selective Extraction of NSAIDs From Environmental Water 13058 3
...bruary 22, 2009--Researchers at the Dana-Farber Ca...r Medical Research (Burnham) and the Centers for D...the identification of human monoclonal antibodies ...fluenza A viruses, including avian influenza A (H5...d some seasonal influenza viruses. These antibodie...
...L, N.J., Feb. 18 BIO-key International, Inc. (OTC...lease fourth quarter 2008 financial results on Tue...In conjunction with the release, BIO-key has sched...ve over the Internet on Tuesday, February 24, 2009... BIO-key International, Inc. Fourth Quarter 2...
...e quick decline of a tiny shrimp-like species, kno... aggressive population growth of non-native quagga...As invasive mussel numbers increase, food sources ...ily and unilaterally declined. , A recent researc...ratory published,this week in Freshwater Biology ...
Other Biology News:Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses 2Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses 3BIO-key(R) Announces Fourth Quarter and 2008 Year-End Earnings Release and Conference Call Schedule 2
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 /PR...aq: DCGN ) today announced the approval of all of ...rt for the District of Delaware,(the "Bankruptcy C...n for,relief under Chapter 11 of the United States... The orders issued by the Bankruptcy Court all...
(Date:11/24/2009)..., SAN MATEO, Calif., Nov. 24 /PRNewswire-FirstCall...ceutical company focused on developing and commerc...d today that Anthony DiTonno, President and Chief ...21st Annual Piper Jaffray Health Care Conference, ...ce Hotel in New York, New York. ,, Mr. DiTonno...
(Date:11/24/2009)...ATTLE, Nov. 24 Blue Marble Energy ...ssa Public Development Authority (OPDA) were recen...nity Economic Revitalization Board (CERB) in a pri...irst specialty biochemical biorefinery in Lincoln ...antly speed the development of our biorefinery and...
(Date:11/24/2009)... Primary efficacy endpoint has been met for pat...rial cancer, , QUEBEC CITY, Nov. 24 /PRNewswi...ZS ; TSX: AEZ) (the "Company"), a global biopharma...oncology, today announced positive efficacy data f...ptide conjugate, AEZS-108 (formerly AN-152), in pa...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
.../Xinhua-PRNewswire-FirstCall/ --,China Biologic Pr... "the,Company"), one of the leading plasma-based p...f China ("PRC"), today announced that the Company,...Drug Administration,("SFDA") (1) to start the prod...od product prepared from plasma and (2) to commenc...
...PRNewswire/ -- Today, Tigermed,Consulting Ltd. joi...in,their CRO Service Alliance CROSA that provides ...nies. Tigermed,s expertise in clinical,development...aceutical,development capabilities of the alliance...Sciences entered into a,CRO Service Alliance in Ma...
...FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ...cused on,endocrine therapy and oncology, today ann..., Chairman and CEO of Andros Men,s Health Institut...er Presentation in a Poster,Session at the 23rd An...h,was held March 26-28, 2008 in Milan, Italy. Titl...
Other Biology Technology:China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex 2China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex 3Shanghai CRO Service Alliance Adds Clinical Development Capabilities 2Shanghai CRO Service Alliance Adds Clinical Development Capabilities 3AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan 2AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan 3AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan 4AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan 5AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan 6
...stone and M.W. Turner (1997). • This book des...production of high-quality antibodies, the use of ... antibodies and antigens, the latest ELISA techniq...assays for detecting cell-surface molecules (cell-...
Propidium Iodide (1 mg/ml). from BioVision
Vybrant Apoptosis Assay Kit #7 - Hoechst 33342/YO-PRO-1/propidium iodide - 200 assays from Molecular Probes (Invitrogen)
Rat TIMP-1 ELISA Kit from R&D Systems
Biology Products: